TY - JOUR
T1 - Impact of left ventricular to mitral valve ring mismatch on recurrent ischemic mitral regurgitation after ring annuloplasty
AU - Capoulade, Romain
AU - Zeng, Xin
AU - Overbey, Jessica R.
AU - Ailawadi, Gorav
AU - Alexander, John H.
AU - Ascheim, Deborah
AU - Bowdish, Michael
AU - Gelijns, Annetine C.
AU - Grayburn, Paul
AU - Kron, Irving L.
AU - Levine, Robert A.
AU - Mack, Michael J.
AU - Melnitchouk, Serguei
AU - Michler, Robert E.
AU - Mullen, John C.
AU - O'Gara, Patrick
AU - Parides, Michael K.
AU - Smith, Peter
AU - Voisine, Pierre
AU - Hung, Judy
N1 - Funding Information:
This work was supported by a cooperative agreement (U01 HL088942) funded by the National Heart, Lung, and Blood Institute and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health and the Canadian Institutes of Health Research. This work was supported in part by National Institutes of Health/National Heart, Lung, and Blood Institute R01 HL092101 (Dr Hung) and R01 HL109506 and HL129088 (Dr Levine). Dr Capoulade is supported by a postdoctoral fellowship grant from the Canadian Institutes of Health Research.
Publisher Copyright:
© 2016 American Heart Association, Inc.
PY - 2016/10/25
Y1 - 2016/10/25
N2 - Background: In ischemic mitral regurgitation (IMR), ring annuloplasty is associated with a significant rate of recurrent MR. Ring size is based on intertrigonal distance without consideration of left ventricular (LV) size. However, LV size is an important determinant of mitral valve (MV) leaflet tethering before and after repair. We aimed to determine whether LV-MV ring mismatch (mismatch of LV size relative to ring size) is associated with recurrent MR in patients with IMR after restrictive ring annuloplasty. Methods: Patients with moderate or severe IMR from the 2 Cardiothoracic Surgical Trials Network IMR trials who received MV repair were examined at 1 year after surgery. Baseline LV size was assessed by LV end-diastolic dimension and LV end-systolic dimension (LVESd). LV-MV ring mismatch was calculated as the ratio of LV to ring size (LV end-diastolic dimension/ring size and LVESd/ring size). Results: At 1 year after ring annuloplasty, 45 of 214 patients with MV repair (21%) had moderate or greater MR. In univariable logistic regression analysis, larger LVESd (P=0.02) and LVESd/ring size (P=0.007) were associated with recurrent MR. In multivariable models adjusted for age, sex, baseline LV ejection fraction, and severe IMR, only LVESd/ring size (odd ratio per 0.5 increase, 2.20; 95% confidence interval, 1.05-4.62; P=0.038) remained significantly associated with 1-year MR recurrence. Conclusions: LV-MV ring size mismatch is associated with increased risk of MR recurrence. This finding may be helpful in guiding choice of ring size to prevent recurrent MR in patients undergoing MV repair and in identifying patients who may benefit from MV repair with additional subvalvular intervention or MV replacement rather than repair alone. Clinical Trial Registration: URL:http://clinicaltrials.gov. Unique identifiers: NCT00806988 and NCT00807040.
AB - Background: In ischemic mitral regurgitation (IMR), ring annuloplasty is associated with a significant rate of recurrent MR. Ring size is based on intertrigonal distance without consideration of left ventricular (LV) size. However, LV size is an important determinant of mitral valve (MV) leaflet tethering before and after repair. We aimed to determine whether LV-MV ring mismatch (mismatch of LV size relative to ring size) is associated with recurrent MR in patients with IMR after restrictive ring annuloplasty. Methods: Patients with moderate or severe IMR from the 2 Cardiothoracic Surgical Trials Network IMR trials who received MV repair were examined at 1 year after surgery. Baseline LV size was assessed by LV end-diastolic dimension and LV end-systolic dimension (LVESd). LV-MV ring mismatch was calculated as the ratio of LV to ring size (LV end-diastolic dimension/ring size and LVESd/ring size). Results: At 1 year after ring annuloplasty, 45 of 214 patients with MV repair (21%) had moderate or greater MR. In univariable logistic regression analysis, larger LVESd (P=0.02) and LVESd/ring size (P=0.007) were associated with recurrent MR. In multivariable models adjusted for age, sex, baseline LV ejection fraction, and severe IMR, only LVESd/ring size (odd ratio per 0.5 increase, 2.20; 95% confidence interval, 1.05-4.62; P=0.038) remained significantly associated with 1-year MR recurrence. Conclusions: LV-MV ring size mismatch is associated with increased risk of MR recurrence. This finding may be helpful in guiding choice of ring size to prevent recurrent MR in patients undergoing MV repair and in identifying patients who may benefit from MV repair with additional subvalvular intervention or MV replacement rather than repair alone. Clinical Trial Registration: URL:http://clinicaltrials.gov. Unique identifiers: NCT00806988 and NCT00807040.
KW - ischemic heart disease
KW - mitral regurgitation
KW - mitral valve
KW - mitral valve annuloplasty
UR - http://www.scopus.com/inward/record.url?scp=84992616489&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84992616489&partnerID=8YFLogxK
U2 - 10.1161/CIRCULATIONAHA.115.021014
DO - 10.1161/CIRCULATIONAHA.115.021014
M3 - Article
C2 - 27777294
AN - SCOPUS:84992616489
SN - 0009-7322
VL - 134
SP - 1247
EP - 1256
JO - Circulation
JF - Circulation
IS - 17
ER -